A promoter assay also demonstrated that IL-6 promoter activity was highly enhanced in the group of MSN overexpression compared to the tumor cells with MSN depletion (Fig. 3F and Supplementary Fig. 3D). The gene discussed is IL6; the disease is neoplasm.